Price Target Archives - Page 10 of 2160

2 minute read

Arcturus’ Inhaled mRNA Therapeutic In Cystic Fibrosis Study Highlights Potential Amid Competitive Landscape: Analyst

June 7, 2:44 PM

Arcturus Therapeutics shared Phase 1 and Phase 1b trial results for ARCT-032, an inhaled mRNA therapeutic for cystic fibrosis, showing FEV1 improvements and safety .

ARCT

2 minute read

Goldman Sachs Optimistic About Regenxbio’s Gene Therapy Pipeline, Sees Over 160% Upside

By Vandana Singh

June 7, 2:30 PM

Goldman Sachs initiates coverage on RGNX, citing potential of gene therapy platform.

ABBV

2 minute read

ASML Remains Top Pick In EU Semicaps, Analyst Highlights Key Role In AI Infrastructure And Multiple Expansion

By Anusuya Lahiri

June 7, 2:29 PM

BofA Securities analyst reiterated Buy rating on ASML Holding N.V. with a raised price target, reflecting higher confidence in demand for EUV tools and higher gross margin. ASML remains top pick in EU Semicaps due to its irreplicable role in AI infrastructure buildout.

ASML

3 minute read

Lyft Competing In Lock-step With Uber Technologies: Analysts Eye ‘Multiple Shots’ On Goal For Growth

By Nabaparna Bhattacharya

June 7, 2:13 PM

Lyft's FY27 targets reveal anticipated growth, prompting mixed analyst reactions, with upgrades, downgrades, and price forecast adjustments.

LYFT

2 minute read

Skechers Stock Set For Growth As Footwear Trends Remain Solid: BofA Analyst

By Shivani Kumaresan

June 7, 1:16 PM

Bank of America analyst Christopher Nardone has upgraded Skechers USA to Buy, raising the price target from $71 to $87. Nardone cites an improving wholesale environment, solid footwear trends, and conservative 2H sales guidance.

BIRK

2 minute read

Ciena Sees ‘Early Signs Of A Recovery,’ 3 Analysts Dive Into Q2 Results

By Priya Nigam

June 7, 12:44 PM

Ciena shows early signs of recovery and positive analyst takeaways. Yet, its share price declined and analysts lowered their forecasts.

CIEN

1 minute read

IFF’s Focus On Health And Environment Set To Drive Stock Momentum, Says Analyst

By Lekha Gupta

June 7, 12:37 PM

Oppenheimer initiates coverage on IFF at Outperform rating with $116 price target. Analyst sees potential for shareholder base shift and ongoing growth. Estimated EPS of $3.94 in FY24, $4.28 in FY25, and $4.61 in FY26. Investors can gain exposure through MVAL and IVEG.

IFF

1 minute read

Sunoco Looks Attractive: Analyst Cites Pullback, Upcoming Guidance As Catalysts

By Lekha Gupta

June 7, 12:29 PM

Stifel analyst upgrades Sunoco LP to Buy and maintains price target of $62.00. Believes upcoming guidance could boost unit price, estimates EBITDA of $1.48B in FY24 and $1.79B in FY25.

AMZA

3 minute read

DocuSign Reports A ‘Skinny Beat’ With ‘Street’s Calibration To The New Cadence May Take A Quarter Or Two’

By Priya Nigam

June 7, 11:30 AM

DocuSign reported upbeat Q1 results, but the beat was less than in previous quarters. Management issued tempered expectations for near-term growth. Analysts have mixed opinions.

ADBE

2 minute read

Casey’s Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

By Avi Kapoor

June 7, 10:50 AM

Casey’s General Stores, Inc. (NASDAQ:CASY) is set to release fourth-quarter financial results, after the closing bell on Tuesday.…

CASY